Performance and safety of femoral central venous catheters in pediatric autologous peripheral blood stem cell collection.

about

Performance and safety of femoral central venous catheters in pediatric autologous peripheral blood stem cell collection.

Item

http://www.wikidata.org/entity/Q38796575

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Performance and safety of femo ...... al blood stem cell collection.

@en

type

Item

label

Performance and safety of femo ...... al blood stem cell collection.

@en

prefLabel

Performance and safety of femo ...... al blood stem cell collection.

@en

P1476

Performance and safety of femo ...... ral blood stem cell collection

@en

P2093

Chisa Yamada

http://www.w3.org/2001/XMLSchema#string

Dawn Webb

http://www.w3.org/2001/XMLSchema#string

Robertson Davenport

http://www.w3.org/2001/XMLSchema#string

Sandra Hoffmann

http://www.w3.org/2001/XMLSchema#string

Sung Won Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens.

Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses.

Large-volume leukapheresis procedure for peripheral blood progenitor cell collection in children weighing 15 kg or less: efficacy and safety evaluation.

Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease.

Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience.

PBSC collection in extremely low weight infants: a single-center experience.

Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods

The impact of recent vincristine on human hematopoietic progenitor cell collection in pediatric patients with central nervous system tumors.

Physiology and pharmacology of plerixafor.

P304

501-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCA.21548

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laura Cooling

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485045

http://www.w3.org/2001/XMLSchema#string

P921

catheterization